False messages circulating on social media prompted Brazilians to seek the Pneumo 23 vaccine at primary health clinics under the mistaken claim that the shot had been opened to anyone over the age of 58 in Brazil's public healthcare network (SUS). Municipal health authorities in São Paulo clarified that national vaccination guidelines have not changed and that the vaccine remains restricted to specific clinical groups.

The misinformation led to confusion and unnecessary demand at basic health units across São Paulo, where individuals reported arriving at clinics only to be turned away. Health officials stressed that the 23-valent pneumococcal polysaccharide vaccine is not distributed to the general adult population based solely on age.

Eligibility rules and medical requirements

Under official protocols from the National Immunization Program, Pneumo 23 is designated strictly for two categories: adults aged 60 and older living in long-term care facilities, such as nursing homes, and individuals aged 2 and older with severe underlying conditions, including immunodeficiencies, chronic lung diseases, and congenital heart defects.

According to Simone Garcia, a nurse with São Paulo's Municipal Immunization Program, receiving the vaccine requires a medical order. Patients visiting primary clinics or Reference Centers for Special Immunobiologicals (Cries) must present a clinical report detailing the medical indication for either the Pneumo 13 or Pneumo 23 vaccine, which is then formally reviewed before administration.

For young children, pneumococcal protection follows standard routine schedules: Pneumo 20 at 2 months of age, Pneumo 10 at 4 months, and a Pneumo 20 booster at 12 months.

Patients managing qualifying chronic conditions should consult their attending physician to secure the required medical report before visiting a clinic. Individuals without clinical indications or long-term care residence should not seek the vaccine at local health units, helping prevent unnecessary overcrowding.